By Michael Le Page , Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool Two woman in Ripollet, Catalonia wearing face masks outside a coronavirus testing area.PAU BARRENA/AFP via Getty Images Latest coronavirus news as of 5 pm on 12 August Germany and Spain among a growing list of western…
The race to develop an effective vaccine against the novel coronavirus gathered pace this week, as clinical trials on humans were approved in Germany and launched in the UK. Though there are now around 150 development projects worldwide, the German and British plans are among only five clinical trials on humans which have been approved…
Gain a global perspective on the US and go beyond with curated news and analysis from 600 journalists in 50+ countries covering politics, business, innovation, trends and more. Choose your subscription Not sure which package to choose?Try full access for 4 weeks For 4 weeks receive unlimited Premium digital access to the FT's trusted, award-winning…
April 22, 2020 | 7:45am | Updated April 22, 2020 | 10:37am Germany and the United Kingdom are forging ahead with plans for clinical trials using human volunteers in the race for a vaccine against COVID-19, according to reports. The Paul Ehrlich Institute in Germany on Wednesday green-lighted the trials for a vaccine developed by…
3 min read This story is part of a series on 10 life-saving medical breakthroughs. Click here to read the rest. ANTONIO TORRES, A 24-year-old from Denver, used to spend six hours each day bathing and meticulously wrapping the red, raw skin along his shoulders and spine. “My wounds take up a large percentage of
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting marketing authorization for Moderna’s new RNA-based vaccine, mNexspike, for preventing COVID-19 in people aged 12 years or older. The vaccine was approved in May 2025 by the US FDA for individuals aged 65 years or older or aged 12-64 years
KFF Health News chief Washington correspondent Julie Rovner discussed Affordable Care Act subsidies on Crooked Media’s What a Day on Dec. 10 and on Slate’s What Next on Dec. 9. Click here to hear Rovner on What a Day. Click here to hear Rovner on What Next. KFF Health News Washington health policy reporter Amanda